Schedule 13G ownership disclosure

CALCIMEDICA INC

Common Stock, par value $0.0001 per share · CUSIP: 38942Q202

Event date: 2025-09-01

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Avenue Venture Opportunities Fund II, L.P.

    Shares: 1,359,553.00 · Class: 8.87%

  • Avenue Capital Management II, L.P.

    Shares: 1,359,553.00 · Class: 8.87%

  • Avenue Venture Opportunities Partners II, LLC

    Shares: 1,359,553.00 · Class: 8.87%

  • GL Venture Opportunities Partners II, LLC

    Shares: 1,359,553.00 · Class: 8.87%

  • Marc Lasry

    Shares: 1,359,553.00 · Class: 8.87%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001829126-25-007253
Form type
SCHEDULE 13G/A
Filer
Avenue Venture Opportunities Fund II, L.P.
CIK
CIK 1886343
Filed
Sep 09, 2025
Reporting period
Sep 01, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub